drugset / Trial / NCT04175301

Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.

NCT04175301

Phase 2 Active not recruiting 15 enrolled Stony Brook University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a pilot randomized control trial (RCT) to explore the effects of hydrogen rich water on quality of life in patients with high grade gliomas, receiving focal radiation therapy to the brain concurrent with chemotherapy with Temozolomide.

Timeline

Start
2019-10-31
Primary completion
2026-09-05
Completion
2027-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrogen Unknown 1.6 ppm Oral

Indications